130 related articles for article (PubMed ID: 946143)
1. The interaction of growth hormone, somatomedin and oestrogen in patients with Turner's syndrome.
Saenger P; Schwartz E; Wiedemann E; Levine LS; Tsai M; New MI
Acta Endocrinol (Copenh); 1976 Jan; 81(1):9-18. PubMed ID: 946143
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactive somatomedin B in acromegaly and in Turner's syndrome.
Benker G; Spira G; Zäh W; Tharandt L; Hackenberg K; Reinwein D
Clin Endocrinol (Oxf); 1979 Oct; 11(4):357-65. PubMed ID: 519875
[TBL] [Abstract][Full Text] [Related]
3. Growth in Turner's syndrome: long term treatment with low dose ethinyl estradiol.
Martínez A; Heinrich JJ; Domené H; Escobar ME; Jasper H; Montuori E; Bergadá G
J Clin Endocrinol Metab; 1987 Aug; 65(2):253-7. PubMed ID: 3597706
[TBL] [Abstract][Full Text] [Related]
4. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
Mauras N; Rogol AD; Veldhuis JD
J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone, somatomedin levels and growth regulation in Turner's syndrome.
Ranke MB; Blum WF; Haug F; Rosendahl W; Attanasio A; Enders H; Gupta D; Bierich JR
Acta Endocrinol (Copenh); 1987 Nov; 116(3):305-13. PubMed ID: 3687318
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute high dose and chronic low dose estrogen on plasma somatomedin-C and growth in patients with Turner's syndrome.
Copeland KC
J Clin Endocrinol Metab; 1988 Jun; 66(6):1278-82. PubMed ID: 3372687
[TBL] [Abstract][Full Text] [Related]
7. Serum thymidine activity and somatomedin-C levels in children and adolescents with Turner's syndrome: effect of chronic estrogen and progestogen replacement therapy.
Guidoux S; Bozzola M; Larizza D; Schimpff RM
Horm Res; 1986; 24(4):256-62. PubMed ID: 3781484
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone secretion in Turner's syndrome and influence of oxandrolone and ethinyl oestradiol.
Massarano AA; Brook CG; Hindmarsh PC; Pringle PJ; Teale JD; Stanhope R; Preece MA
Arch Dis Child; 1989 Apr; 64(4):587-92. PubMed ID: 2751332
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone treatment in girls with Turner's syndrome. A review of the literature.
Wilton P
Acta Paediatr Scand; 1987 Mar; 76(2):193-200. PubMed ID: 3296625
[TBL] [Abstract][Full Text] [Related]
10. Testosterone-estradiol-binding globulin in patients with Turner's syndrome: effects of estrogens and acute growth hormone administration.
Bergink EW; Wolf DL; Wittliff JL; Bruining GJ; Bryson MF; Forbes GB
J Clin Endocrinol Metab; 1976 Jun; 42(6):1018-23. PubMed ID: 180042
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone therapy for patients with Turner's syndrome.
Singer-Granick C; Lee PA; Foley TP; Becker DJ
Horm Res; 1986; 24(4):246-50. PubMed ID: 3781482
[TBL] [Abstract][Full Text] [Related]
12. Twenty-four hour plasma GH, FSH and LH profiles in patients with Turner's syndrome.
Villadolid MC; Takano K; Hizuka N; Asakawa K; Sukegawa I; Horikawa R; Shizume K
Endocrinol Jpn; 1988 Feb; 35(1):71-81. PubMed ID: 3135180
[TBL] [Abstract][Full Text] [Related]
13. Decreased growth hormone response to growth hormone-releasing hormone in Turner's syndrome: relation to body weight and adiposity.
Reiter JC; Craen M; Van Vliet G
Acta Endocrinol (Copenh); 1991 Jul; 125(1):38-42. PubMed ID: 1872123
[TBL] [Abstract][Full Text] [Related]
14. Effects of luteinizing hormone-releasing hormone (LRH) upon bioactive and immunoreactive serum LH in patients with Turner's syndrome before and after oestrogen treatment.
Celani MF; Montanini V; Marrama P
Acta Endocrinol (Copenh); 1985 Jul; 109(3):304-8. PubMed ID: 3895799
[TBL] [Abstract][Full Text] [Related]
15. Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol.
Massa G; Bouillon R; Vanderschueren-Lodeweyckx M
J Clin Endocrinol Metab; 1992 Nov; 75(5):1298-302. PubMed ID: 1430092
[TBL] [Abstract][Full Text] [Related]
16. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone and somatomedin C during post-menopausal replacement therapy with oestrogen alone and in combination with an antioestrogen.
Fröhlander N; von Schoultz B
Maturitas; 1988 Mar; 9(4):297-302. PubMed ID: 3380016
[TBL] [Abstract][Full Text] [Related]
18. Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome.
Lu PW; Cowell CT; Jimenez M; Simpson JM; Silink M
Arch Dis Child; 1991 Oct; 66(10):1184-90. PubMed ID: 1953000
[TBL] [Abstract][Full Text] [Related]
19. Somatomedin A in human serum, determined by radioreceptor assay.
Takano K; Hall K; Ritzén M; Iselius L; Sievertsson H
Acta Endocrinol (Copenh); 1976 Jul; 82(3):449-59. PubMed ID: 947120
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone reserve capacity in Turner's syndrome.
Laczi F; Julesz J; Janáky T; László FA
Horm Metab Res; 1979 Dec; 11(12):664-6. PubMed ID: 395061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
